Celldex Therapeutics, Inc.
NASDAQ:CLDX
Overview | Financials
Company Name | Celldex Therapeutics, Inc. |
Symbol | CLDX |
Currency | USD |
Price | 27.6 |
Market Cap | 1,831,099,920 |
Dividend Yield | 0% |
52-week-range | 22.93 - 53.18 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Anthony S. Marucci M.B.A. |
Website | https://www.celldex.com |
An error occurred while fetching data.
About Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody that binds
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD